Aquarius Equity Partners is private equity manager focused on high-growth businesses. The Firm manages a variety of funds, from seed stage (investments up to £350,000) to later-stage transactions (investments up to £5 million). The Firm's later-stage fund looks for opportunities in pharmaceuticals, biotechnology, medical devices, specialty chemicals and environmental technology. Aquarius was formed in 2005 and is based in Manchester.
Join Mergr to view the latest updates and news from Manchester-based Aquarius Equity Partners.
Aquarius Equity Partners’ most common sectors for investment are life science (84%) and medical products (17%). The Firm’s most common investment types include growth capital (50%) and buyout (lbo, mbo, mbi) (34%).
In the last 3 years, Aquarius Equity Partners has exited 2 companies. The Firm’s most common exit type is trade sale (50%). Aquarius Equity Partners’ largest (disclosed) exit occurred in 2014 when it sold Brabant Pharma for $20M.
Join Mergr to view Aquarius Equity Partners’ full profile and discover more small private equity firms just like it.
Month to month. Cancel anytime.